Jonathan Frampton

Jonathan Frampton is an experienced business development professional specializing in bioproduction and biotechnology sectors. Currently serving as Vice President of Business Development at ProteoNic since May 2023, Jonathan focuses on enhancing cost-efficiency and scalability through innovative vector technology for therapeutic proteins and viral vectors. With a robust background that includes roles such as Director at JMF Biotech Consulting and Head of Business Development at Qkine, Jonathan has extensive expertise in commercial growth strategies, coaching, and market development. Previous roles include Chief Commercial Officer at Metisox, Corporate Development Partner and Key Account Partner at Horizon Discovery, and various positions at Diagenode and Abcam. Jonathan holds a PhD in Biochemistry and a BSc in Biology from the University of Sussex.